1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Medication Adherence Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Advancement/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Medication Adherence Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.1.1. Software Centric
5.2.1.2. Hardware Centric
5.2.2. By Medication
5.2.2.1. Cardiovascular
5.2.2.2. Central nervous systems
5.2.2.3. Diabetes
5.2.2.4. Oncology
5.2.2.5. Gastrointestinal
5.2.2.6. Musculoskeletal
5.2.2.7. Others
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. The Asia Pacific
5.2.3.4. Latin America
5.2.3.5. The Middle East and Africa
6. North America Medication Adherence Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Medication
6.2.3. By Country
6.2.3.1. United States
6.2.3.2. Canada
7. Europe Medication Adherence Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Medication
7.2.3. By Country
7.2.3.1. Germany
7.2.3.2. United Kingdom
7.2.3.3. Italy
7.2.3.4. France
7.2.3.5. Spain
7.2.3.6. Rest of Europe
8. The Asia Pacific Medication Adherence Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Medication
8.2.3. By Country
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. South Korea
8.2.3.5. Rest of Asia Pacific
9. Latin America Medication Adherence Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Medication
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Mexico
9.2.3.3. Rest of Latin America
10. The Middle East & Africa Medication Adherence Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Medication
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis, 2021
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership.)
12. Impact of Covid-19 on Global Medication Adherence Market Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
13.1. HealthEra
13.2. McKesson Corporation
13.3. Health Beacon
13.4. eLucid mHealth
13.5. Tinylogics
13.6. Johnson & Johnson Services Inc
13.7. Renesas
13.8. Qualcomm Incorporated
13.9. Adherence Solutions
13.10. Allscripts Healthcare solutions
13.11. SMRxT Inc
13.12. Vaica
13.13. Health Window
13.14. Seamless MD
13.15. Merck KGaA
13.16. Datos Ltd
13.17. AstraZeneca
13.18. Helium Health
13.19. Cardinal Health
13.20. Catalia Health
14. Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable